Emerging Therapies Are Changing the Melanoma Treatment Landscape
Source: Pharmacy Times, August 2022
Specialty pharmacists play critical role in supporting treatment adherence.
Although melanoma accounts for approximately 1% of skin cancer diagnoses, it is responsible for a large portion of lives lost to the disease, with approximately 8000 deaths predicted to occur in the United States in 2022. A main reason for the high morbidity rate is that melanoma is much more likely to metastasize than other skin cancers.
Despite the high morbidity rate of melanoma, the disease accounts for only 5.6% of all new cancer cases in the United States, with the incidence of melanoma increasing steadily for several decades.1 Based on this statistic, the American Cancer Society estimates that 100,000 new melanoma diagnoses will occur in the United States in 2022.2